Revance Is A Global Biotechnology And Aesthetics Company Based In Nashvilletennesseewith Additional Operations In Newarkcaliforniaformed Through The Merger Of Revance Therapeutics And Crown Laboratoriesthe Company Specializes In Neurotoxin Based Therapeutics And Advanced Skincare Solutionsfounded In 2002Revance Serves Patients And Consumers In 60 Countriesfocusing On Aesthetic And Therapeutic Innovations The Company S Aesthetic Portfolio Includes Daxibotulinumtoxina Lanmdaxi An Fda Approved Neurotoxin For Treating Frown Lines And Cervical Dystoniaand Skinpenaprecisionan Fda Cleared Microneedling Devicerevance Also Offers Biojuvea A Microbiome Friendly Skincare Lineits Therapeutic Pipeline Features Daxi For Cervical Dystonia And Investigational Applications For Chronic Migrainehyperhidrosisand Plantar Fasciitisrevance Invests Significantly In Research And Development To Enhance Its Product Offerings And Maintain Its Position As A Leader In The Industry
